Fibroblast Growth Factor Receptors as Novel Therapeutic Targets in SNF5-Deleted Malignant Rhabdoid Tumors

Malignant rhabdoid tumors (MRTs) are aggressive pediatric cancers arising in brain, kidney and soft tissues, which are characterized by loss of the tumor suppressor SNF5/SMARCB1. MRTs are poorly responsive to chemotherapy and thus a high unmet clinical need exists for novel therapies for MRT patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Wöhrle, Simon, Weiss, Andreas, Ito, Moriko, Kauffmann, Audrey, Murakami, Masato, Jagani, Zainab, Thuery, Anne, Bauer-Probst, Beatrice, Reimann, Flavia, Stamm, Christelle, Pornon, Astrid, Romanet, Vincent, Guagnano, Vito, Brümmendorf, Thomas, Sellers, William R., Hofmann, Francesco, Roberts, Charles W. M., Graus Porta, Diana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3813701/
https://www.ncbi.nlm.nih.gov/pubmed/24204904
http://dx.doi.org/10.1371/journal.pone.0077652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3813701/
https://www.ncbi.nlm.nih.gov/pubmed/24204904
http://dx.doi.org/10.1371/journal.pone.0077652

Ejemplares similares